COMMUNIQUÉS West-GlobeNewswire

BioPorto and Roche Diagnostics sign a distribution agreement for NGAL
09/02/2018
BioPorto A/S (“BioPorto”) has entered into a global distribution agreement with Roche, under which BioPorto will deliver a neutrophil gelatinase-associated lipocalin (NGAL) test for use on Roche’s cobas c 501/c 502 [...]
CellaVision AB Year-end Bulletin 2017
09/02/2018
Stable quarter with continued strategic initiatives October 1 - December 31, 2017 Net sales increased by 5 percent to SEK 76.1 million (72.8). Organic growth was 6 % (14). Operating profit increased to SEK 21.7 million [...]
NeuroSearch A/S releasing Annual Report 2017
09/02/2018
Announcement no. 1-18 Page 1 of 2 Company announcement 9 February 2018 The full version of the Annual Report 2017 for NeuroSearch is available in the enclosed PDF file. In 2017, NeuroSearch (NEUR) realised an operating [...]
iTeos Therapeutics to Present New Preclinical Data from A2A Receptor Antagonist and Anti-TIGIT Antibody Programs at Molecular Medicine Tri-Conference
09/02/2018
iTeos Therapeutics to Present New Preclinical Data from A2A Receptor Antagonist and Anti-TIGIT Antibody Programs at Molecular Medicine Tri-Conference Two Phase 1 trials to start in 2018 for A 2A receptor antagonist and [...]
NeuroSearch A/S releasing Annual Report 2017
09/02/2018
Announcement no. 1-18 Page 1 of 2 Company announcement 9 February 2018 The full version of the Annual Report 2017 for NeuroSearch is available in the enclosed PDF file. In 2017, NeuroSearch (NEUR) realised an operating [...]
Outcome from DSMB Safety Review and Extension of TACTI-mel Phase I Clinical Trial
09/02/2018
SYDNEY, Australia, Feb. 08, 2018 (GLOBE NEWSWIRE) -- Immutep Limited (ASX:IMM) (NASDAQ: IMMP ) (“Immutep” or the “Company”), announced today that the Database Safety Monitoring Board (“DSMB”) confirmed that the [...]
Pacific Biosciences Announces Outcome of First Phase of Patent Litigation Against Oxford Nanopore
09/02/2018
MENLO PARK, Calif., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq: PACB ) announced today that the U.S. International Trade Commission (the “ITC”) has terminated its investigation [...]
miRagen Therapeutics, Inc. Prices Public Offering of Common Stock
09/02/2018
BOULDER, Colo., Feb. 08, 2018 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN ), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today [...]
FDA Grants Orphan Drug Designation (ODD) for Xeris Pharmaceuticals' Ready-to-Use Glucagon for the Treatment of Hyperinsulinemic Hypoglycemia (HH). Results from Phase 2a Study in Post-Bariatric Hypoglycemia, Associated with HH, Published.
09/02/2018
Chicago, IL, Feb. 08, 2018 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc. (“Xeris”), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and [...]
Aclaris Therapeutics to Present Data on ESKATA™ (Hydrogen Peroxide) Topical Solution, 40% (w/w) at the 2018 American Academy of Dermatology Annual Meeting
08/02/2018
ESKATA™ received FDA approval for the treatment of raised seborrheic keratoses (SKs) in December 2017 WAYNE, Pa., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS ), a dermatologist-led [...]
Accelerate Diagnostics to Host Q4 and Full-Year 2017 Earnings Call on February 15, 2018
08/02/2018
TUCSON, Ariz., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. will host a conference call on Thursday, February 15, 2018 to review its fourth quarter and full-year financial results for 2017. President [...]
Chembio Diagnostics Announces Proposed Public Offering of Common Stock
08/02/2018
MEDFORD, N.Y., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (NASDAQ: CEMI ) (“Chembio”), a leader in point-of-care diagnostic tests for infectious diseases, announced today that it has commenced an [...]
Chembio Diagnostics Announces Major New Tender Win and Certain Preliminary 2017 Financial Results
08/02/2018
MEDFORD, N.Y., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (NASDAQ: CEMI ) (“Chembio”), a leader in point-of-care diagnostic tests for infectious diseases, announced today that it has won a three-year [...]
BioStem Technologies Adds Chief Revenue Officer to Executive Team
08/02/2018
Pompano Beach, FL, Feb. 08, 2018 (GLOBE NEWSWIRE) -- (GLOBE NEWSWIRE) – BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem” or the “Company”), a global life sciences corporation, providing innovative technologies [...]
Aduro Biotech to Present at the Leerink Partners 7th Annual Global Healthcare Conference
08/02/2018
BERKELEY, Calif., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO ) today announced that Stephen T. Isaacs, chairman, president and chief executive officer of Aduro, will present at the Leerink [...]
AzurRx BioPharma to Present at the 2018 BIO CEO & Investor Conference (February 12th)
08/02/2018
BROOKLYN, N.Y., Feb. 08, 2018 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX ) (“AzurRx” or the “Company”), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal [...]
CRISPR Therapeutics Announces Transition of Bill Lundberg, MD
08/02/2018
ZUG, Switzerland and CAMBRIDGE, Mass., Feb. 08, 2018 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP ), a biopharmaceutical company focused on developing transformative gene-based medicines for serious diseases, [...]
The Ensign Group Reports Fourth Quarter and Fiscal Year 2017 Results
08/02/2018
MISSION VIEJO, Calif., Feb. 08, 2018 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG ), the parent company of the Ensign™ group of skilled nursing, rehabilitative care services, home health, home care, hospice [...]
The Cooper Companies Announces Release Date for First Quarter 2018
08/02/2018
PLEASANTON, Calif., Feb. 08, 2018 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE: COO ) today announced it will release first quarter 2018 financial results on Thursday, March 8, 2018, at 4:15 PM ET. Following the [...]

Pages